2016 American Society of Hematology Annual Meeting *

December 3-6, 2016; San Diego, California
This program provides coverage of the 2016 ASH annual meeting with PowerPoint summaries and expert analysis of the most clinically relevant study results with downloadable highlights slidesets. Topics include lymphomas/CLL, leukemias, myeloma, and other hematologic malignancies.

Share

Program Content

No activities added yet

No activities added yet

No activities added yet

No activities added yet

Activities

NIVO or IPI ± AZA in MDS
Nivolumab or Ipilimumab ± Azacitidine in Treatment-Naive or HMA-Failed Myelodysplastic Syndromes
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022
MPD-RC 112: PegIFN α-2a vs HU in PV/ET
MPD-RC 112: Frontline Peginterferon α-2a vs Hydroxyurea in High-Risk Polycythemia Vera and Essential Thrombocythemia
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022
Ropeginterferon α-2b vs HU in PV
Phase III PROUD-PV: Ropeginterferon α-2b Noninferior to Hydroxyurea in Polycythemia Vera
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Provided by

ProCE Banner

Supporters

This activity is supported by educational grants from

Amgen, Inc.

Celgene

Incyte

Merck & Co., Inc.

Seagen

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.